ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026
Obstructive sleep apnea screening performance of the STOP-BANG questionnaire and a home sleep apnea test device in atrial fibrillation ablation candidates.
Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- STOP-Bang Modification for Screening Treatment-Relevant Obstructive Sleep Apnea in Cluster Headache: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Obstructive sleep apnea: Proposed scoring system.World journal of methodology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundObstructive sleep apnea (OSA) contributes to the onset and progression of atrial fibrillation (AF) and negatively affects AF ablation outcomes. OSA screening in AF patients is often conducted with the STOP-BANG questionnaire, although its validation is lacking. This study aims to evaluate the screening value of the STOP-BANG questionnaire and a home sleep apnea test (HSAT) device for OSA in patients referred for AF ablation.
methodsPatients referred for their first AF ablation and without prior OSA diagnosis underwent both the STOP-BANG questionnaire and a HSAT device based on peripheral arterial tonometry (PAT). Patients with a PAT-derived apnea-hypopnea index (pAHI) of 5 or more events per hour subsequently underwent clinical polysomnography (PSG). This PSG was used for definitive OSA diagnosis and to determine the diagnostic values of the STOP-BANG and HSAT.
resultsOf 67 patients initially screened with the STOP-BANG and HSAT, 58 completed PSG after excluding those with pAHI < 5/hour or who declined further testing. Among these 58 patients, STOP-BANG (score ≥ 3) correctly screened 84% of cases, while HSAT was more accurate (97%, P-value < 0.002). Among the 67 initially screened patients, 56 (84%) received a new OSA diagnosis. Of these, 21 (38%) had mild OSA, 17 (30%) moderate OSA and 18 (32%) severe OSA.
conclusionThe high OSA prevalence highlights the importance of OSA screening in patients referred for AF ablation. In this cohort, HSAT demonstrated superior accuracy, compared to the STOP-BANG questionnaire and may be considered the preferred OSA screening tool in outpatient AF clinics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.